Novavax announced that it will postpone filing its Covid-19 vaccine with the Food and Drug Administration for approval for emergency use until the fourth quarter. The biotech company’s shares slipped 10% after the bell. The company has applied for approval in India, Indonesia and the Philippines. Plans to submit the vaccine to the World Health …
Continue reading “FDA submitting for emergency functions postponed to This fall”